It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

pharmaceuticals

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Oxford-AstraZeneca COVID-19 shot less effective against South African variant, study says

World / Science & Health Feb 7, 2021

Oxford-AstraZeneca COVID-19 shot less effective against South African variant, study says

British drugmaker AstraZeneca said on Saturday its vaccine developed with Oxford University appeared to offer only limited protection against mild disease caused by the South African variant of COVID-19, based on early data from a trial. The study from South Africa's University of the Witwatersrand ...

Marijuana law reform in Japan contingent on the message

National / Media | MEDIA MIX Feb 6, 2021

Marijuana law reform in Japan contingent on the message

by Philip Brasor

Japanese authorities have demonstrated a strong resistance to trends in other countries to decriminalize and even commercialize the drug's medicinal and recreational consumption.

Japan is moving closer to vaccinations: Here's how the rollout will work

National | EXPLAINER Feb 5, 2021

Japan is moving closer to vaccinations: Here's how the rollout will work

by Osamu Tsukimori

The government has begun to set out its inoculation schedule, but there are concerns over delivery hiccups.

Macron calls on China to be more transparent on COVID-19 shots

Asia Pacific Feb 5, 2021

Macron calls on China to be more transparent on COVID-19 shots

by Ania Nussbaum

"It seems that we can have more information about the Russian vaccines,” he said, citing a recent study and Russia’s initiatives to register its Sputnik V shot with EU authorities.

AstraZeneca and Pfizer vaccines to be combined in Oxford trial

World / Science & Health Feb 4, 2021

AstraZeneca and Pfizer vaccines to be combined in Oxford trial

The trial will allow researchers to see whether two shots of different vaccines produce better or worse results than two doses of the same product.

BioNTech 'confident' it will meet Japan's COVID-19 vaccine demand

National Feb 3, 2021

BioNTech 'confident' it will meet Japan's COVID-19 vaccine demand

Pfizer and BioNTech have increased manufacturing capacity to more than 2 billion doses a year from 1.3 billion to meet demand.

AstraZeneca boosts COVID-19 vaccine deliveries to EU amid chaotic rollout

World Feb 1, 2021

AstraZeneca boosts COVID-19 vaccine deliveries to EU amid chaotic rollout

AstraZeneca PLC will deliver 9 million additional vaccine doses to the European Union in the first quarter of this year as the bloc tries to get its chaotic inoculation drive on track. European Commission President Ursula von der Leyen announced Sunday on Twitter that the ...

COVID-19 mutations undercut optimism even as more vaccines near

World Jan 31, 2021

COVID-19 mutations undercut optimism even as more vaccines near

by Robert Langreth

Mutations that likely confer partial resistance to vaccines and antibody treatments are now prevalent in both South Africa and Brazil, and they are threatening to spread worldwide.

Faced with a vaccine emergency, the EU made an enemy of everyone

World Jan 31, 2021

Faced with a vaccine emergency, the EU made an enemy of everyone

by Alberto Nardelli, Dara Doyle, Suzi Ring and Nikos Chrysoloras

What began as a bid to bring transparency has spiraled into chaotic mud-slinging that some fear could spur a trade row amid the pandemic.

COVID-19 vaccine 89.3% effective in U.K. trial but less so in South Africa, Novavax says

World Jan 29, 2021

COVID-19 vaccine 89.3% effective in U.K. trial but less so in South Africa, Novavax says

The U.S. company believes the vaccine was 85.6% effective against the highly transmissible U.K. variant, which was also circulating during the study.

Racing the virus: Why tweaking vaccines to fight variants won't be simple

World | FOCUS Jan 29, 2021

Racing the virus: Why tweaking vaccines to fight variants won't be simple

by Julie Steenhuysen and Michael Erman

After developing and rolling out COVID-19 vaccines at record speed, drugmakers are already facing variants of the rapidly-evolving coronavirus that may render them ineffective.

Faced with vaccine shortages, EU set to impose export controls

World Jan 29, 2021

Faced with vaccine shortages, EU set to impose export controls

The new rules will allow member states to block exports if companies have not already delivered a sufficient number of dosages to EU members, as set out in existing purchase agreements.

« 1 … 21 22 23 … 42 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times